Mitsubishi, Medipal Of Japan To Invest More In China's Sinopharm Network
This article was originally published in PharmAsia News
Executive Summary
Japanese drug distributors Mitsubishi and Medipal Holdings said they have joined in buying additional shares of Sinopharm Medicine Holding Beijing Huahong to expand the distribution network of both companies in China